RSS Search

 News  Feeds  Images  Tags  Search Shortcuts

Feedsfarm.com > Feeds > bizjournals.com Health Care:Biotechnology headlines > Archive

bizjournals.com Health Care:Biotechnology headlines News Archive

Health Care:Biotechnology headlines from the week of November 13, 2006

http://www.bizjournals.com/rss/feed/vertical_subtopic/32

Page: 1 of 5 bizjournals.com Health Care:Biotechnology headlines

  1. Regenerating vision
  2. Startup betting there's a big market in plastic surgery products
  3. Biotech goes Dutch, follows in Google's IPO footsteps
  4. Celera finds genes that point to heart attack risk
  5. Illinois courts Kansas City-area stem cell researchers
  6. Biotech industry grappling with question of who pays for what
  7. Seeking room to grow
  8. Inventing a new bio model
  9. George Scangos: CEO combines big pharma experience, pioneer spirit
  10. Risky business: Covering biotech is a complex job
  11. Local drug manufacturing facility part of Glaxo purchase
  12. N.C. Biotech Center opens Greenville, Wilmington offices
  13. Teranode raises $9.5M
  14. Blunt honored for support of bioscience industry
  15. Oregon has largest percentage increase for R&D funding
  16. StemCells moves ahead on spinal cord and infant disease treatments
  17. UT fills new research position
  18. JoCo college gets $1.5M for bioscience training
  19. CoolTouch wins FDA OK for new vein treatment
  20. Stem cell company licenses Ukraine research center
  21. Revivicor sells regenerative therapy rights
  22. Intarcia scraps IPO
  23. Genzyme expands overseas operations
  24. Intarcia Therapeutics scraps IPO
  25. Hockaday takes KC life sciences helm
  26. CORTEX details plans for 173-acre tract
  27. Patent office scrutinized as lawsuits rise
  28. Biotechnology boot camp offers to school non-scientists
  29. Human Genome Sciences approves pay raises for 3 key execs
  30. Three at Stanford win NIH awards, funding
  31. Specialty Labs getting $314.7 M buyout
  32. Ceptor files for MS drug patent
  33. New medical school dedicated
  34. San Antonio leaders defend city's bioscience push
  35. Luring away our biotechs
  36. Biotech fever
  37. Little value yet, but officials spend millions
  38. NY's support for biotech research trails rivals' efforts
  39. Biotech fever
  40. D-FW seeking capital, execs
  41. R&D in W-S: New director takes reins as research park growth accelerates
  42. Stem-cell research advocates lobby for Pa. support
  43. Birmingham eyes growth in biotech
  44. Japanese firm plans to invest $20M in city
  45. States chase biotech bucks
  46. In the genes: Dog-DNA sleuths linked to startup
  47. Venture capital is critical for new biotech firm
  48. Authority, incubator boost Colo. biotech
  49. Region's lively biotech sector has long way to go
  50. Cellular Bioengineering wins major R&D award
  51. Geron betting on cancer vaccine
  52. 'Resource team' approach replaces life sciences liaison
  53. For California, chase is on for stem-cell research stars
  54. Collaboration is key to local biotech effort
  55. XenoPort is poised for growth after IPO
  56. HGS gets contract for anthrax drug
  57. UNM receives $23 million for vaccine research
  58. Student at RPI named to Glamour magazine list
  59. GTx re-announces sale of common stock
  60. ThemoGenesis inks deal with GE
  61. Genentech expands deal with Colorado company
  62. Xenogen inks second deal with Gene Logic
  63. Hawaii Biotech signs licensing deal
  64. UAB lures top biomed expert from Georgia Tech
  65. Morgan Hill bio-incubator a rival?
  66. Univ. of Minnesota to pull plug on genomics company
  67. Biotech Center ponders venture-linked loans
  68. Law firm is bullish on biotech business
  69. Biotech's new CEO nabs $48M in financing
  70. Dayton has opportunity to be big in biotech niches
  71. CepTor earns $1.5M payment
  72. Psst... Cambridge markets itself to life sciences world, quietly
  73. The Scripps mother ship
  74. East Coast VC firm sets its sights on NM
  75. BioGenex claims one victory in ongoing patent battles
  76. In ballot battle, biotech prescribes low dose of itself
  77. UNCW seeks biotech gems from the sea
  78. Biotech stocks bolstered by positive recent tests
  79. When companies leave, state needs to ask the right question
  80. Biotech startups struggle to find suitable property
  81. Alexandria's spree points to allure of area biotech
  82. UM-St. Louis plans $5 million high-tech incubator
  83. UT Southwestern professor elected to national advisory group
  84. Bio-Rad inks second research deal with Caliper
  85. Affymetrix joins collaborative effort to combat childhood cancer
  86. Sepracor Q3 aided by drug sale
  87. Affymetrix, PathWork collaborate on cancer tests
  88. VaxGen to file late financial reports in 2006
  89. DNAPrint genomics deal aims at speeding drug development
  90. EPA picks UNC for part of $9M environmental bioinformatics initiative
  91. UNC wins $4.5M EPA grant for new center
  92. Drug delays push Neoprobe loss
  93. Dynatherm Medical names CEO
  94. Canadian biotech firms heading to Denver
  95. AirGate relocating headquarters
  96. Singapore tops Sacramento to lure firm
  97. Amgen files patent suit against Roche
  98. Tech firms honored at annual awards
  99. Lexicon, Taconic Farms team up for knockout mice project
  100. Maryland biotech lands $804,000 NIH grant